S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$78.46
-0.7%
$82.49
$69.44
$88.23
$38.69B0.91911,219 shs757,057 shs
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$14.32
+0.1%
$15.89
$13.62
$21.95
$5.03B0.36482,628 shs552,422 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$125.92
-0.8%
$128.30
$119.59
$148.62
$13.98B0.911.03 million shs873,688 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
-0.77%-3.88%-6.11%+1.86%+11.10%
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
+1.78%-8.50%-9.20%-3.90%-12.64%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.34%-3.52%-0.91%-5.40%-10.64%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
2.3885 of 5 stars
3.32.00.00.01.40.82.5
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
2.7239 of 5 stars
3.33.00.00.02.50.02.5
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.8441 of 5 stars
2.14.04.24.72.72.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.64
Moderate Buy$91.2216.27% Upside
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
2.50
Moderate Buy$19.6837.44% Upside
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.18
Hold$144.1814.50% Upside

Current Analyst Ratings

Latest BLCO, ALC, and DGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Alcon Inc. stock logo
ALC
Alcon
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$100.00
4/4/2024
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$16.50 ➝ $17.00
3/20/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$145.00
3/14/2024
Alcon Inc. stock logo
ALC
Alcon
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Perform
3/13/2024
Alcon Inc. stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$95.00
3/4/2024
Alcon Inc. stock logo
ALC
Alcon
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$90.00 ➝ $100.00
3/1/2024
Alcon Inc. stock logo
ALC
Alcon
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$92.00 ➝ $100.00
2/29/2024
Alcon Inc. stock logo
ALC
Alcon
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$87.00 ➝ $92.00
2/29/2024
Alcon Inc. stock logo
ALC
Alcon
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$93.00 ➝ $96.60
2/28/2024
Alcon Inc. stock logo
ALC
Alcon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$86.00
2/26/2024
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $18.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.46B4.09$5.17 per share15.18$41.83 per share1.88
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$4.15B1.21$1.94 per share7.37$19.72 per share0.73
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$9.25B1.51$12.59 per share10.00$56.41 per share2.23

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$1.9640.0322.612.0410.30%6.75%4.63%5/14/2024 (Estimated)
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
-$260M-$0.74N/A16.271.36-6.27%3.70%2.11%5/1/2024 (Confirmed)
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$854M$7.4916.8113.402.759.23%15.79%7.40%4/23/2024 (Confirmed)

Latest BLCO, ALC, and DGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$0.09N/A-$0.09N/AN/AN/A  
4/23/2024N/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$1.89N/A-$1.89N/AN/AN/A  
2/27/2024Q4 2023
Alcon Inc. stock logo
ALC
Alcon
$0.68$0.70+$0.02$0.54$2.34 billion$2.33 billion  
2/21/202412/31/2023
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
$0.17$0.24+$0.07$0.63$1.11 billion$1.17 billion    
2/1/2024Q4 23
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.11$2.15+$0.04$2.60$2.25 billion$2.29 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
N/AN/AN/AN/A4 Years
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
N/AN/AN/AN/AN/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.842.26%+8.08%37.92%13 Years

Latest BLCO, ALC, and DGX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.752.34%4/5/20244/8/20244/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.22
2.28
1.34
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
0.65
1.74
1.09
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.70
1.31
1.20

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
11.07%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
1.52%
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
N/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.79%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,000493.10 million485.61 millionOptionable
Bausch + Lomb Co. stock logo
BLCO
Bausch + Lomb
13,300351.40 millionN/AOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
48,000111.06 million110.18 millionOptionable

BLCO, ALC, and DGX Headlines

SourceHeadline
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Cerity Partners LLCQuest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Cerity Partners LLC
marketbeat.com - April 18 at 5:39 AM
Everence Capital Management Inc. Purchases 11,780 Shares of Quest Diagnostics Incorporated (NYSE:DGX)Everence Capital Management Inc. Purchases 11,780 Shares of Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 17 at 9:25 AM
Quest Diagnostics (NYSE:DGX) Lowered to Hold at StockNews.comQuest Diagnostics (NYSE:DGX) Lowered to Hold at StockNews.com
americanbankingnews.com - April 17 at 2:46 AM
SVB Wealth LLC Has $12.57 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)SVB Wealth LLC Has $12.57 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 16 at 11:28 AM
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to DeclineEarnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
zacks.com - April 16 at 11:06 AM
Quest Diagnostics (DGX) Scheduled to Post Earnings on TuesdayQuest Diagnostics (DGX) Scheduled to Post Earnings on Tuesday
americanbankingnews.com - April 16 at 1:28 AM
Quest Diagnostics (DGX) to Post Q1 Earnings: Whats in Store?Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
zacks.com - April 15 at 10:51 AM
Aquila Investment Management LLC Buys Shares of 8,000 Quest Diagnostics Incorporated (NYSE:DGX)Aquila Investment Management LLC Buys Shares of 8,000 Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 14 at 9:39 AM
International Assets Investment Management LLC Buys 52,609 Shares of Quest Diagnostics Incorporated (NYSE:DGX)International Assets Investment Management LLC Buys 52,609 Shares of Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 13 at 5:30 AM
Sequoia Financial Advisors LLC Buys New Position in Quest Diagnostics Incorporated (NYSE:DGX)Sequoia Financial Advisors LLC Buys New Position in Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 12 at 6:36 AM
Q3 2024 EPS Estimates for Quest Diagnostics Incorporated (NYSE:DGX) Boosted by Zacks ResearchQ3 2024 EPS Estimates for Quest Diagnostics Incorporated (NYSE:DGX) Boosted by Zacks Research
americanbankingnews.com - April 11 at 2:08 AM
Q3 2024 Earnings Estimate for Quest Diagnostics Incorporated (NYSE:DGX) Issued By Zacks ResearchQ3 2024 Earnings Estimate for Quest Diagnostics Incorporated (NYSE:DGX) Issued By Zacks Research
marketbeat.com - April 10 at 8:28 AM
Validea Detailed Fundamental Analysis - DGXValidea Detailed Fundamental Analysis - DGX
nasdaq.com - April 10 at 4:27 AM
Quest Diagnostics (NYSE:DGX) Upgraded by StockNews.com to "Buy"Quest Diagnostics (NYSE:DGX) Upgraded by StockNews.com to "Buy"
americanbankingnews.com - April 10 at 3:24 AM
BioNexus Gene Lab (NASDAQ:BGLC) versus Quest Diagnostics (NYSE:DGX) Critical ContrastBioNexus Gene Lab (NASDAQ:BGLC) versus Quest Diagnostics (NYSE:DGX) Critical Contrast
americanbankingnews.com - April 10 at 2:28 AM
Quest Diagnostics (NYSE:DGX) Upgraded to Buy by StockNews.comQuest Diagnostics (NYSE:DGX) Upgraded to Buy by StockNews.com
marketbeat.com - April 9 at 11:13 PM
My Quest Story - Jessica ClowMy Quest Story - Jessica Clow
finance.yahoo.com - April 9 at 12:26 PM
Olstein Capital Management L.P. Has $8 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)Olstein Capital Management L.P. Has $8 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 8 at 9:55 AM
Leerink Partnrs Weighs in on Quest Diagnostics Incorporateds Q1 2024 Earnings (NYSE:DGX)Leerink Partnrs Weighs in on Quest Diagnostics Incorporated's Q1 2024 Earnings (NYSE:DGX)
americanbankingnews.com - April 8 at 1:36 AM
DekaBank Deutsche Girozentrale Has $106.89 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)DekaBank Deutsche Girozentrale Has $106.89 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)
marketbeat.com - April 6 at 12:28 PM
Quest Diagnostics (NYSE:DGX) investors will be pleased with their respectable 62% return over the last five yearsQuest Diagnostics' (NYSE:DGX) investors will be pleased with their respectable 62% return over the last five years
finance.yahoo.com - April 5 at 7:52 AM
Quest Diagnostics (DGX) Collaborates With Broad Clinical LabsQuest Diagnostics (DGX) Collaborates With Broad Clinical Labs
zacks.com - April 3 at 12:26 PM
Quest, Broad Clinical Labs to Assess Genome Sequencing as First-Line Test for Developmental DelayQuest, Broad Clinical Labs to Assess Genome Sequencing as First-Line Test for Developmental Delay
360dx.com - April 2 at 10:52 PM
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental DelayQuest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
prnewswire.com - April 2 at 7:57 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alcon logo

Alcon

NYSE:ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Bausch + Lomb logo

Bausch + Lomb

NYSE:BLCO
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Quest Diagnostics logo

Quest Diagnostics

NYSE:DGX
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.